Pathfinder Cell Therapy, Inc. Stock Other OTC
Equities
PFND
US70319A1060
Biotechnology & Medical Research
Financials (USD)
Sales 2013 | 0.05 | Sales 2014 | - | Capitalization | 534K |
---|---|---|---|---|---|
Net income 2013 | -1M | Net income 2014 | -1M | EV / Sales 2013 | 246,023,185 x |
Net Debt 2013 | 3.94M | Net Debt 2014 | 4.96M | EV / Sales 2014 | - |
P/E ratio 2013 |
-5.48
x | P/E ratio 2014 |
-0.38
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Rick Franklin
CEO | Chief Executive Officer | 78 | 11-09-01 |
John Benson
DFI | Director of Finance/CFO | 62 | 11-09-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rick Franklin
CEO | Chief Executive Officer | 78 | 11-09-01 |
John Benson
DFI | Director of Finance/CFO | 62 | 11-09-01 |
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.84B | |
+46.85% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |